13A-1070810
TW I785268、US,EP,CN Pending
Despite of the anti-tumor activity of natural killer (NK) cells, adoptive NK cell transfer had shown little clinical benefit in treating solid tumors. This invention provides a method of NK cells and cyclophosphamide combination therapy, which not only eradicates tumor but also induces protective immune memory for prevention of recurrence in approximately 80% of mice under either tumor-bearing or tumor-resect conditions in a pre-clinical triple negative breast cancer model. Therefore, this invention harnesses the anti-tumor activity of NK cells for the treatment of solid tumors.
- Combination Treatment is more effective
- Inhibit tumor recurrence and/or reduce tumor recurrence
- Cancer treatment
- Cell therapy
Nan-Shih Liao, Shih-Wen Huang, Zhen-Qi, Wu, Yein-Gei Lai, Yae-Huei Liou
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Combination of natural killer cells with cyclophosphamide for the treatment of cancer